Related Experiment Video

Updated: Aug 17, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Cytokine network in human multiple myeloma

B Klein1, R Bataille

  • 1Laboratory of Immuno-hématologic Oncology, Hôtel-Dieu, Nantes, France.

Hematology/Oncology Clinics of North America
|April 1, 1992
PubMed

Insights

Interleukin-6 (IL-6) drives multiple myeloma growth and aggressiveness, impacting patient prognosis. Targeting IL-6 offers a promising therapeutic strategy for this hematologic malignancy.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Elevated Interleukin-6 (IL-6) levels are observed in 37% of multiple myeloma (MM) patients at diagnosis.
  • High IL-6 is linked to increased disease aggressiveness, myeloma cell proliferation, and poorer patient outcomes.
  • IL-6 is primarily produced by the tumor microenvironment, not myeloma cells themselves.

Purpose of the Study:

  • To investigate the role of IL-6 and other cytokines in multiple myeloma cell proliferation.
  • To explore the therapeutic potential of targeting IL-6 in MM treatment.

Main Methods:

  • Establishing IL-6-dependent myeloma cell lines in vitro.
  • Evaluating the effects of anti-IL-6 therapies on myeloma cell proliferation in vivo.
  • Assessing the synergistic effects of hematopoietic cytokines (GM-CSF, IL-3, IL-5, G-CSF) with IL-6.
  • Investigating the impact of Interferon-alpha (IFN-alpha), Tumor Necrosis Factor (TNF), and Interferon-gamma (IFN-gamma) on IL-6-mediated myeloma cell growth.

Main Results:

  • IL-6 acts as a significant growth factor for malignant plasmablastic cells.
  • Anti-IL-6 therapies effectively inhibit myeloma cell proliferation in patients with advanced disease.
  • Hematopoietic cytokines synergize with IL-6 to promote myeloma cell proliferation.
  • IFN-alpha and TNF induce autocrine IL-6 production, enabling autonomous cell growth, while IFN-gamma inhibits IL-6-mediated proliferation.

Conclusions:

  • Cytokines, particularly IL-6, play a critical role in regulating the multiple myeloma clone.
  • Understanding these cytokine interactions has direct implications for developing targeted MM therapies.
  • Targeting IL-6 and related cytokine pathways represents a viable therapeutic strategy for multiple myeloma.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...